Liver injury during highly pathogenic human coronavirus infections.
Identifieur interne : 002610 ( Ncbi/Merge ); précédent : 002609; suivant : 002611Liver injury during highly pathogenic human coronavirus infections.
Auteurs : Ling Xu [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mengji Lu [République populaire de Chine] ; Dongliang Yang [République populaire de Chine] ; Xin Zheng [République populaire de Chine]Source :
- Liver international : official journal of the International Association for the Study of the Liver [ 1478-3231 ] ; 2020.
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the pathogen of 2019 novel coronavirus disease (COVID-19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS-CoV-2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS-CoV-2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases. Similarly, previous studies have shown that liver damage was common in the patients infected by the other two highly pathogenic coronavirus - severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), and associated with the severity of diseases. In this review, the characteristics and mechanism of liver injury caused by SARS-CoV, MERS-CoV as well as SARS-CoV-2 infection were summarized, which may provide help for further studies on the liver injury of COVID-19.
DOI: 10.1111/liv.14435
PubMed: 32170806
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000161
- to stream PubMed, to step Curation: 000161
- to stream PubMed, to step Checkpoint: 000159
Links to Exploration step
pubmed:32170806Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Liver injury during highly pathogenic human coronavirus infections.</title><author><name sortKey="Xu, Ling" sort="Xu, Ling" uniqKey="Xu L" first="Ling" last="Xu">Ling Xu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Liu, Jia" sort="Liu, Jia" uniqKey="Liu J" first="Jia" last="Liu">Jia Liu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Lu, Mengji" sort="Lu, Mengji" uniqKey="Lu M" first="Mengji" last="Lu">Mengji Lu</name><affiliation wicri:level="3"><nlm:affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Yang, Dongliang" sort="Yang, Dongliang" uniqKey="Yang D" first="Dongliang" last="Yang">Dongliang Yang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Zheng, Xin" sort="Zheng, Xin" uniqKey="Zheng X" first="Xin" last="Zheng">Xin Zheng</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32170806</idno><idno type="pmid">32170806</idno><idno type="doi">10.1111/liv.14435</idno><idno type="wicri:Area/PubMed/Corpus">000161</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000161</idno><idno type="wicri:Area/PubMed/Curation">000161</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000161</idno><idno type="wicri:Area/PubMed/Checkpoint">000159</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000159</idno><idno type="wicri:Area/Ncbi/Merge">002610</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Liver injury during highly pathogenic human coronavirus infections.</title><author><name sortKey="Xu, Ling" sort="Xu, Ling" uniqKey="Xu L" first="Ling" last="Xu">Ling Xu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Liu, Jia" sort="Liu, Jia" uniqKey="Liu J" first="Jia" last="Liu">Jia Liu</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Lu, Mengji" sort="Lu, Mengji" uniqKey="Lu M" first="Mengji" last="Lu">Mengji Lu</name><affiliation wicri:level="3"><nlm:affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Yang, Dongliang" sort="Yang, Dongliang" uniqKey="Yang D" first="Dongliang" last="Yang">Dongliang Yang</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author><author><name sortKey="Zheng, Xin" sort="Zheng, Xin" uniqKey="Zheng X" first="Xin" last="Zheng">Xin Zheng</name><affiliation wicri:level="3"><nlm:affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan</wicri:regionArea><placeName><settlement type="city">Wuhan</settlement><region type="région">Hubei</region></placeName></affiliation></author></analytic><series><title level="j">Liver international : official journal of the International Association for the Study of the Liver</title><idno type="eISSN">1478-3231</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the pathogen of 2019 novel coronavirus disease (COVID-19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS-CoV-2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS-CoV-2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases. Similarly, previous studies have shown that liver damage was common in the patients infected by the other two highly pathogenic coronavirus - severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), and associated with the severity of diseases. In this review, the characteristics and mechanism of liver injury caused by SARS-CoV, MERS-CoV as well as SARS-CoV-2 infection were summarized, which may provide help for further studies on the liver injury of COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32170806</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1478-3231</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>Liver international : official journal of the International Association for the Study of the Liver</Title><ISOAbbreviation>Liver Int.</ISOAbbreviation></Journal><ArticleTitle>Liver injury during highly pathogenic human coronavirus infections.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/liv.14435</ELocationID><Abstract><AbstractText>The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), the pathogen of 2019 novel coronavirus disease (COVID-19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS-CoV-2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS-CoV-2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases. Similarly, previous studies have shown that liver damage was common in the patients infected by the other two highly pathogenic coronavirus - severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), and associated with the severity of diseases. In this review, the characteristics and mechanism of liver injury caused by SARS-CoV, MERS-CoV as well as SARS-CoV-2 infection were summarized, which may provide help for further studies on the liver injury of COVID-19.</AbstractText><CopyrightInformation>© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mengji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dongliang</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xin</ForeName><Initials>X</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-6564-7807</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020kfyXGYJ016</GrantID><Agency>Fundamental Research Funds for the Central Universities</Agency><Country></Country></Grant><Grant><GrantID>2020kfyXGYJ028</GrantID><Agency>Fundamental Research Funds for the Central Universities</Agency><Country></Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Liver Int</MedlineTA><NlmUniqueID>101160857</NlmUniqueID><ISSNLinking>1478-3223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MERS</Keyword><Keyword MajorTopicYN="N">SARS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">liver injury</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>02</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>03</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>03</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32170806</ArticleId><ArticleId IdType="doi">10.1111/liv.14435</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24(6):490-502.</Citation></Reference><Reference><Citation>Peiris J, Lai ST, Poon L, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361(9366):1319-1325.</Citation></Reference><Reference><Citation>Kupferschmidt K. Researchers scramble to understand camel connection to MERS. Science. 2013;341(6147):702.</Citation></Reference><Reference><Citation>Zhu NA, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.</Citation></Reference><Reference><Citation>Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967-1976.</Citation></Reference><Reference><Citation>Chang H-L, Chen K-T, Lai S-K, et al. Hematological and biochemical factors predicting SARS fatality in Taiwan. J Formos Med Assoc. 2006;105(6):439-450.</Citation></Reference><Reference><Citation>Liu Z, Guo J. Dynamic changes of liver function and myocardial enzyme in 259 patients with severe acute respiratory syndrome. J Clin Hepatol. 2003;3:129-131.</Citation></Reference><Reference><Citation>Lu Y, Yin C, Tang X, et al. Clinical characteristics and mechanism of liver function injury in 250 patients with severe acute respiratory syndrome. Chin J Mod Med. 2004;23:121-123.</Citation></Reference><Reference><Citation>Tie Z, Zhang T, Zhang M, et al. Prevention and treatment of liver injury in SARS patients-222 cases analysis. Beijing Med J. 2004;5:318-320.</Citation></Reference><Reference><Citation>Zhao L, Xing H, Xu L. Effect of SARS associated coronavirus on peripheral blood picture and liver function. Chin Crit Care Med. 2004;11:660-663.</Citation></Reference><Reference><Citation>Yang Z, Xu M, Yi J. The clinic characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome. Chin J Infect Dis. 2003;4:13-15.</Citation></Reference><Reference><Citation>Duan Z, Chen Y, Zhang J, et al. Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome. Chin J Hepatol. 2003;11(8):493-496.</Citation></Reference><Reference><Citation>Huang Y, Gao Z. Study of the relationship SARS and hepatitis virus B. Chin J Clini Hepatol. 2003;6:342-343.</Citation></Reference><Reference><Citation>Wang J-T, Sheng W-H, Fang C-T, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10(5):818-824.</Citation></Reference><Reference><Citation>Jiang T, Zhao M, Zhou Z, et al. Clinical feature of liver injury in patients with severe acute respiratory syndrome. Chin J Mod Med. 2004;23:139-141.</Citation></Reference><Reference><Citation>Lu S-N, Lee C-M, Lin M-C, et al. Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome. Am J Trop Med Hyg. 2004;71(2):125-128.</Citation></Reference><Reference><Citation>Duan X, Liu Z, He R, et al. The dynamic change of liver injury in patients with severe acute respiratory syndrome. Chin J Hepatol. 2004;7:60.</Citation></Reference><Reference><Citation>Chau T-N, Lee K-C, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302-310.</Citation></Reference><Reference><Citation>Lu J, Zhao J, Li N, et al. Ultrastructure pathology of all organs in severe acute respiratory syndrome. Chin J Diag Pathol. 2003;4:72-77.</Citation></Reference><Reference><Citation>Ding Y, He LI, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622-630.</Citation></Reference><Reference><Citation>Farcas G, Poutanen S, Mazzulli T, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191(2):193-197.</Citation></Reference><Reference><Citation>Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-454.</Citation></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis M, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Patho. 2004;203(2):631-637.</Citation></Reference><Reference><Citation>Tan Y-J, Fielding BC, Goh P-Y, et al. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol. 2004;78(24):14043-14047.</Citation></Reference><Reference><Citation>Yang Z, Xu M, Yi JQ, et al. Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome. Hepatobiliary Pancreat Dis Int. 2005;4(1):60-63.</Citation></Reference><Reference><Citation>Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386(9997):995-1007.</Citation></Reference><Reference><Citation>Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301-306.</Citation></Reference><Reference><Citation>Al-Hameed F, Wahla AS, Siddiqui S, et al. Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia. J Intensive Care Med. 2015;31(5):344-348.</Citation></Reference><Reference><Citation>Hwang S-M, Na B-J, Jung Y, et al. Clinical and laboratory findings of Middle East respiratory syndrome coronavirus infection. Jap J Infect Dis. 2019;72(3):160-167.</Citation></Reference><Reference><Citation>Arabi YM, Al-Omari A, Mandourah Y, et al. Critically Ill patients with the Middle East respiratory syndrome. Crit Care Med. 2017;45(10):1683-1695.</Citation></Reference><Reference><Citation>Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389-397.</Citation></Reference><Reference><Citation>Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752-761.</Citation></Reference><Reference><Citation>Ng DL, Al Hosani F, Keating MK, et al. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014. Am J Patho. 2016;186(3):652-658.</Citation></Reference><Reference><Citation>Alsaad KO, Hajeer AH, Al Balwi M, et al. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology. 2018;72(3):516-524.</Citation></Reference><Reference><Citation>Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251-254.</Citation></Reference><Reference><Citation>Boonacker E, Van Noorden CJF. The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol. 2003;82(2):53-73.</Citation></Reference><Reference><Citation>Zhao G, Jiang Y, Qiu H, et al. Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus. PLoS ONE. 2015;10(12):e145561.</Citation></Reference><Reference><Citation>Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8-13.</Citation></Reference><Reference><Citation>WHO. Coronavirus disease. 2019. http://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed March 6, 2020.</Citation></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.</Citation></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020; in press. https://doi.org/10.1101/2020.02.06.20020974</Citation></Reference><Reference><Citation>Cai Q, Huang D, Ou P, et al. COVID-19 in a Designated Infectious Diseases HospitalOutside Hubei Province, China. medRxiv. 2020; in press. https://doi.org/10.1101/2020.02.17.20024018</Citation></Reference><Reference><Citation>Fan Z, Chen L, Jun LI, et al. Clinical features of COVID-19-related liver damage. medRxiv. 2020; in press. https://doi.org/10.1101/2020.02.26.20026971</Citation></Reference><Reference><Citation>Wang D, Hu BO, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020.</Citation></Reference><Reference><Citation>Cao W. Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. medRxiv. 2020; in press. https://doi.org/10.1101/2020.02.23.20026963</Citation></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.</Citation></Reference><Reference><Citation>Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis, 2020. https://doi.org/10.1016/S1473-3099(20)30086-4</Citation></Reference><Reference><Citation>Xu X-W, Wu X-X, Jiang X-G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;m606.</Citation></Reference><Reference><Citation>Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5</Citation></Reference><Reference><Citation>Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 death cases with COVID-19. medRxiv. 2020; in press. https://doi.org/10.1101/2020.02.26.20028191</Citation></Reference><Reference><Citation>Huang Y, Zhou H, Yang R, et al. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv;2020; in press. https://doi.org/10.1101/2020.02.27.20029009</Citation></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Krüger N, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-1 coronavirus receptor2 ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv;2020; in press. https://doi.org/10.1101/2020.01.31.929042</Citation></Reference><Reference><Citation>Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv;2020. https://doi.org/10.1101/2020.02.03.931766</Citation></Reference><Reference><Citation>Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol. 2019;16(5):269-281.</Citation></Reference><Reference><Citation>Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv,2020, in press. https://doi.org/10.1101/2020.02.16.20023671</Citation></Reference><Reference><Citation>Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020. https://doi.org/10.1016/S2213-2600(20)30076-X</Citation></Reference><Reference><Citation>National Health Commission of the People's Republic of China. Diagnosis and Treatment of Coronavirus disease 2019 (Trial Version 7).http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml. Accessed March 6, 2020</Citation></Reference><Reference><Citation>Yu C, Mao Y. Guidelines for the management of drug-induced liver injury. J Prac Hepatol. 2017;20(02):257-274.</Citation></Reference><Reference><Citation>Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302(5643):276-278.</Citation></Reference><Reference><Citation>WHO. Severe Acute Respiratory Syndrome (SARS). 2020. http://www.who.int/csr/sars/en/. Accessed Feburary 24, 2020</Citation></Reference><Reference><Citation>WHO.Middle East respiratory syndrome coronavirus (MERS-CoV). .https://www.who.int/emergencies/mers-cov/en/. Accessed Feburary 24, 2020</Citation></Reference><Reference><Citation>Xiao K, Zhai J, Feng Y, et al. Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins. bioRxiv. 2020. https://doi.org/10.1101/2020.02.17.951335</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country><region><li>Hubei</li></region><settlement><li>Wuhan</li></settlement></list><tree><country name="République populaire de Chine"><region name="Hubei"><name sortKey="Xu, Ling" sort="Xu, Ling" uniqKey="Xu L" first="Ling" last="Xu">Ling Xu</name></region><name sortKey="Liu, Jia" sort="Liu, Jia" uniqKey="Liu J" first="Jia" last="Liu">Jia Liu</name><name sortKey="Lu, Mengji" sort="Lu, Mengji" uniqKey="Lu M" first="Mengji" last="Lu">Mengji Lu</name><name sortKey="Yang, Dongliang" sort="Yang, Dongliang" uniqKey="Yang D" first="Dongliang" last="Yang">Dongliang Yang</name><name sortKey="Zheng, Xin" sort="Zheng, Xin" uniqKey="Zheng X" first="Xin" last="Zheng">Xin Zheng</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002610 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002610 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:32170806
|texte= Liver injury during highly pathogenic human coronavirus infections.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32170806" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |